PLAINSBORO, N.J., Oct. 8, 2008 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NasdaqGS:IART - News) has scheduled a conference call for 9:00 AM ET on Monday, November 10, 2008 to discuss financial results for the third quarter of 2008 and to update forward-looking financial guidance.

The conference call will be hosted by Stuart Essig, President and Chief Executive Officer of Integra, and will be open to all listeners. Additional forward-looking information may be discussed in a question and answer session following the call.

Access to the live call is available by dialing 913-312-1270 or through a webcast via a link provided on the Investor Relations homepage of Integra's website at http://www.Integra-LS.com. Access to a replay is available through November 24, 2008 by dialing 719-457-0820 (PIN 8405173) or through the webcast.

Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is dedicated to improving the quality of life for patients through the development, manufacturing, and marketing of cost-effective surgical implants and medical instruments. Our products are used primarily in neurosurgery, extremity reconstruction, orthopedics and general surgery to treat millions of patients every year. Integra's headquarters are in Plainsboro, New Jersey, and we have research and manufacturing facilities throughout the world. Please visit our website at (http://www.Integra-LS.com).

IART-G

          Integra LifeSciences Holdings Corporation
          John B. Henneman III, Executive Vice President, Finance
           and Administration, Chief Financial Officer
            (609) 936-2481
            jhenneman@Integra-LS.com
          Karen Mroz-Bremner, Senior Manager, Corporate Development
           and Investor Relations
            (609) 936-6929
            karen.mroz-bremner@Integra-LS.com